MBX Biosciences (MBX) News Today $20.36 +0.09 (+0.44%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period MBX Biosciences (NYSE:MBX) Shares Gap Down - Should You Sell?MBX Biosciences (NYSE:MBX) Shares Gap Down - Here's WhyDecember 20 at 11:45 AM | marketbeat.comTeachers Retirement System of The State of Kentucky Purchases Shares of 26,708 MBX Biosciences, Inc. (NYSE:MBX)Teachers Retirement System of The State of Kentucky purchased a new position in MBX Biosciences, Inc. (NYSE:MBX - Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 26,708 shares of the compDecember 19 at 4:39 AM | marketbeat.comMBX Biosciences to Participate in 43rd Annual J.P. Morgan Healthcare ConferenceDecember 18, 2024 | finance.yahoo.comMBX Biosciences (NYSE:MBX) Trading 4.6% Higher - Here's WhyMBX Biosciences (NYSE:MBX) Stock Price Up 4.6% - Time to Buy?December 17, 2024 | marketbeat.comMBX Biosciences (NYSE:MBX) Shares Gap Up - Here's WhyMBX Biosciences (NYSE:MBX) Shares Gap Up - Still a Buy?December 16, 2024 | marketbeat.com46,194 Shares in MBX Biosciences, Inc. (NYSE:MBX) Purchased by The Manufacturers Life Insurance CompanyThe Manufacturers Life Insurance Company acquired a new stake in shares of MBX Biosciences, Inc. (NYSE:MBX - Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 46,194 shares of the company's stock,December 12, 2024 | marketbeat.comWellington Management Group LLP Buys Shares of 2,937,853 MBX Biosciences, Inc. (NYSE:MBX)Wellington Management Group LLP bought a new stake in MBX Biosciences, Inc. (NYSE:MBX - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 2,937,853 shares of the companDecember 11, 2024 | marketbeat.comFrazier Life Sciences Management L.P. Acquires Shares of 5,985,347 MBX Biosciences, Inc. (NYSE:MBX)Frazier Life Sciences Management L.P. bought a new stake in shares of MBX Biosciences, Inc. (NYSE:MBX - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 5,985,347 shares of the company's stock, valued at approximately $155,December 10, 2024 | marketbeat.comMBX Biosciences (NYSE:MBX) Shares Gap Down - What's Next?MBX Biosciences (NYSE:MBX) Shares Gap Down - Here's What HappenedDecember 6, 2024 | marketbeat.comRA Capital Management L.P. Makes New Investment in MBX Biosciences, Inc. (NYSE:MBX)RA Capital Management L.P. bought a new position in shares of MBX Biosciences, Inc. (NYSE:MBX - Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 1,511,334 shares of the comDecember 5, 2024 | marketbeat.comMaven Securities LTD Purchases Shares of 50,000 MBX Biosciences, Inc. (NYSE:MBX)Maven Securities LTD purchased a new stake in shares of MBX Biosciences, Inc. (NYSE:MBX - Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 50,000 shares of the company's stock, valued at approximateDecember 5, 2024 | marketbeat.comMBX Biosciences Announces MBX 2109 Phase 1 Study Results Published in The Journal of Clinical Endocrinology and MetabolismDecember 3, 2024 | markets.businessinsider.comMBX Biosciences announces publication of MBX 2109 Phase 1 study resultsDecember 3, 2024 | markets.businessinsider.comNEA Management Company LLC Makes New $93.90 Million Investment in MBX Biosciences, Inc. (NYSE:MBX)NEA Management Company LLC bought a new position in shares of MBX Biosciences, Inc. (NYSE:MBX - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 3,614,486 shares of the company's stock, valuDecember 1, 2024 | marketbeat.comMBX Biosciences (NYSE:MBX) Shares Down 3.6% - Should You Sell?MBX Biosciences (NYSE:MBX) Stock Price Down 3.6% - Here's WhyNovember 29, 2024 | marketbeat.comBehind the Bell: MBX BiosciencesNovember 25, 2024 | nasdaq.comMBX Biosciences (NYSE:MBX) Shares Up 6.5% - Here's WhyMBX Biosciences (NYSE:MBX) Shares Up 6.5% - Should You Buy?November 22, 2024 | marketbeat.comMBX Biosciences completes phase 1 trial of diabetes drugNovember 20, 2024 | uk.investing.comMBX Biosciences (NYSE:MBX) Shares Gap Down - Here's What HappenedMBX Biosciences (NYSE:MBX) Shares Gap Down - Here's What HappenedNovember 19, 2024 | marketbeat.comMBX Biosciences completes last visit in Phase 1 MBX 1416 trial in hypoglycemiaNovember 19, 2024 | markets.businessinsider.comMBX Biosciences (NYSE:MBX) Shares Gap Up - Time to Buy?MBX Biosciences (NYSE:MBX) Shares Gap Up - Should You Buy?November 18, 2024 | marketbeat.comMBX Biosciences Announces Last Subject Last Visit in Phase 1 Trial of MBX 1416 for the Treatment of Post-Bariatric HypoglycemiaNovember 18, 2024 | globenewswire.comMBX Biosciences, Inc. (MBX)November 15, 2024 | finance.yahoo.comMBX Biosciences (NYSE:MBX) Sets New 1-Year Low - What's Next?MBX Biosciences (NYSE:MBX) Hits New 1-Year Low - Should You Sell?November 15, 2024 | marketbeat.comMBX Biosciences: Decent Potential For Lead Indication, But Need More DataNovember 14, 2024 | seekingalpha.comMBX Biosciences (NYSE:MBX) Shares Gap Down - Time to Sell?MBX Biosciences (NYSE:MBX) Shares Gap Down - Time to Sell?November 11, 2024 | marketbeat.comMBX Biosciences Reports Q3 2024 Financial ProgressNovember 9, 2024 | tipranks.comMBX Biosciences Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 8, 2024 | finance.yahoo.comMBX Biosciences (NYSE:MBX) Shares Up 8.2% - Time to Buy?MBX Biosciences (NYSE:MBX) Shares Up 8.2% - Still a Buy?November 5, 2024 | marketbeat.comMBX Biosciences (NYSE:MBX) Shares Up 6.8% - Here's What HappenedMBX Biosciences (NYSE:MBX) Stock Price Up 6.8% - Here's What HappenedOctober 29, 2024 | marketbeat.comMBX Biosciences (NYSE:MBX) Sets New 52-Week Low - Time to Sell?MBX Biosciences (NYSE:MBX) Reaches New 1-Year Low - Time to Sell?October 28, 2024 | marketbeat.comMBX Biosciences to Participate in Upcoming November Investor ConferencesOctober 28, 2024 | globenewswire.comMBX Biosciences (NYSE:MBX) Shares Down 4.5% - Here's What HappenedMBX Biosciences (NYSE:MBX) Shares Down 4.5% - Here's What HappenedOctober 25, 2024 | marketbeat.comMBX Biosciences, Inc.'s Quiet Period Set To Expire on October 23rd (NYSE:MBX)MBX Biosciences' (NYSE:MBX - Get Free Report) quiet period will end on Wednesday, October 23rd. MBX Biosciences had issued 10,200,000 shares in its public offering on September 13th. The total size of the offering was $163,200,000 based on an initial share price of $16.00. During MBX Biosciences' quiet period, underwriters and any insiders involved in the IPO are prevented from issuing any earnings forecasts or research reports for the company because of SEC regulations. Following the expiration of the company's quiet period, it's expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.October 16, 2024 | marketbeat.comMBX Biosciences (NYSE:MBX) Stock Price Down 4% - Here's WhyMBX Biosciences (NYSE:MBX) Stock Price Down 4% - Here's What HappenedOctober 14, 2024 | marketbeat.comOpening Day: Another trio of biotech IPOs make Friday debutOctober 14, 2024 | finance.yahoo.comMBX Bio drops despite bullish views on StreetOctober 10, 2024 | msn.comBuy Rating Affirmed on MBX Biosciences, Inc. Based on Promising Therapeutic Pipeline and Market PotentialOctober 10, 2024 | markets.businessinsider.comBuy Rating Affirmed for MBX Biosciences on Strong Clinical Progress and Robust Financial PositionOctober 10, 2024 | markets.businessinsider.comMBX Biosciences (NYSE:MBX) Trading 4.6% Higher - What's Next?MBX Biosciences (NYSE:MBX) Trading Up 4.6% - Still a Buy?October 9, 2024 | marketbeat.comMBX Biosciences (NYSE:MBX) Stock Price Down 3.5% - Should You Sell?MBX Biosciences (NYSE:MBX) Stock Price Down 3.5% - Here's WhyOctober 4, 2024 | marketbeat.comMBX Biosciences Presents MBX 2109 Phase 2 Avail™ Hypoparathyroidism Trial Rationale and Design at the ASBMR 2024 Annual MeetingSeptember 30, 2024 | globenewswire.comLast Week's 3 Biotech IPOs Prompt Huge Insider BuyingSeptember 22, 2024 | 247wallst.comEdward T. Mathers Acquires 500,000 Shares of MBX Biosciences, Inc. (NYSE:MBX) StockSeptember 18, 2024 | insidertrades.com Get MBX Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it. Click here to watch this demo and decide for yourself. MBX Media Mentions By Week MBX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MBX News Sentiment▼0.780.60▲Average Medical News Sentiment MBX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MBX Articles This Week▼53▲MBX Articles Average Week Get MBX Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Agios Pharmaceuticals News Today Protagonist Therapeutics News Today Amneal Pharmaceuticals News Today Longboard Pharmaceuticals News Today Ligand Pharmaceuticals News Today Geron News Today NewAmsterdam Pharma News Today IDEAYA Biosciences News Today Centessa Pharmaceuticals News Today Wave Life Sciences News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:MBX) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MBX Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MBX Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MBX Stock Alerts